Business Context and Reporting Period
This Form 8-K filing by Veracyte, Inc. (a Delaware corporation) was submitted on November 21, 2016, reporting events occurring on November 17, 2016. The filing primarily addresses the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation arrangements.
- New CFO Base Salary: $400,000 per year.
- Target Bonus: 50% of eligible annual earnings.
- Equity Grant (Options): 100,000 shares at fair market value, vesting monthly over 36 months starting one year after commencement.
- Equity Grant (RSUs): 25,000 restricted share units vesting on the one-year anniversary.
Material Changes
The material change reported is the appointment of Keith Kennedy as Chief Financial Officer, effective December 6, 2016. Mr. Kennedy replaces the previous CFO (name not specified in this text) and brings prior experience as CEO of MCG Capital Corporation and Managing Director at GE Capital, Inc.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of business risks. It notes that Mr. Kennedy will enter into a Change of Control and Severance Agreement consistent with other executive officers and an Indemnification Agreement. The employment is on an at-will basis.
Investor Verification Checklist
- Verify the effective start date of December 6, 2016, for the new CFO.
- Review the full text of the Change of Control and Severance Agreement to be filed as an exhibit to the 2016 Form 10-K.
- Confirm the vesting schedule details for the 100,000 stock options and 25,000 RSUs.
- Check the press release (Exhibit 99.1) for additional context on the leadership transition.